Split the quote into its parts.
Cost notes as of September 26, 2026.
A September 2026 review covered advertised prices on six national online weight-care websites. Most listed a monthly membership fee, with the medicine charged separately.
Those ads do not tell us the price of your Arizona visit. Ask for a written list of your own costs.
Ask whether tests, delivery and follow-up visits are included. Get the price after any starter offer, too.
Read cash offers with their limits.
On September 26, 2026, drug companies advertised prices for people paying without insurance, mostly from $149 to $499 a month for several weight and diabetes medicines.
For example, semaglutide (Wegovy) tablets had advertised prices from $149 to $299 a month. Tirzepatide (Mounjaro) pens were advertised as starting at $499 a month.
The price depended on the drug, the amount in each pill or shot, and the type of pill or injection package. Some higher-strength products cost more if the next supply was ordered late.
For some semaglutide offers, the starting price applied only to the first two monthly supplies dispensed by the pharmacy.
Ask which date or refill would end your starter price.
The drug companies did not all use the same package for a monthly supply. Some counted one box or one bottle; others counted 28 days of medicine.
Ask how much medicine the quoted price buys and how long that supply is meant to last.
Use the range to open a cost conversation, then request a quote for the exact product and the full care bill.
December 31, 2026 was the end date in the terms for many drug-company offers and savings cards in these notes.
An end date does not tell us what the next price will be.
Ask your plan about the drug and the reason.
Prior authorization means seeking the insurance plan's permission to pay before the pharmacy fills the prescription.
Medicare's usual drug benefit, Part D, still excluded drugs used only for weight loss on September 26, 2026.
A drug may be coverable for another accepted use, such as diabetes, but payment still depends on the plan's drug list and approval rules.
Medicare's temporary Bridge is a separate route.
Bridge programme notes as of September 26, 2026.
Eligible people using Medicare's temporary Bridge programme owe a $50 copay for certain weight medicines, with each supply lasting a month.
A copay is the part paid by the patient.
The programme opens on July 1, 2026; its closing date is December 31, 2027, and it operates outside the usual Part D benefit.
Eligibility starts at age 18 with a qualifying Medicare drug plan: standalone Part D, for example, or a Medicare Advantage plan with drug coverage.
The weight rules use body mass index (BMI) at the start of the medicine; this number comes from your height and weight. The weight threshold is met with a BMI of 35 or higher.
At a BMI of at least 30, one of three health problems is also required. One is heart failure with preserved ejection fraction: heart failure where the heart keeps its squeezing strength. Another is blood pressure with a top reading still above 140 or a bottom reading still above 90, despite two blood-pressure medicines. The third is kidney disease at stage 3a or later; ask your doctor which stage applies.
At a BMI of at least 27, one of these is also required: prediabetes, a past heart attack or a past stroke. Poor blood flow in the limbs that causes symptoms also qualifies at that BMI.
Medicare Part D payment for one of your GLP-1 medicines in 2026 rules out Bridge use in 2026; these drugs control blood sugar or weight. As of September 26, 2026, Medicare had not set the 2027 rule for past drug payments.
Type 2 diabetes rules out Bridge eligibility, even for a request based on weight loss. Ask about payment through the usual Part D plan instead; payment still depends on the plan.
Moderate to severe obstructive sleep apnea, repeated breathing pauses during sleep, also rules people out. So does the liver disease called MASH with moderate to advanced scarring but without the further stage called cirrhosis. A prescription for reducing major heart or stroke risks also goes through Part D.
A prescription and approval of the application are required, along with ongoing changes in eating and physical activity.
Ask the prescriber to check the full application with you, including your diagnoses, blood-pressure readings, plan type and past drug payments. Meeting a weight cutoff alone does not confirm that you qualify.
The $50 payment is excluded when adding up a patient's spending toward the yearly Part D limit. The Bridge also has no extra price help for people with low incomes.
Medicare: the Bridge programmeMedicare: check the eligibility details